Ear, nose and throat manifestations in patients with primary antibody deficiencies

Recurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin...

Full description

Bibliographic Details
Main Authors: Aghamohammadi A, Jalali F, Farhoudi A, Pourpak Z, Rezaei N, Khazali SH, Hosseini Nik H
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2001-07-01
Series:Acta Medica Iranica
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/1150.pdf&manuscript_id=1150
_version_ 1818760425045491712
author Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
author_facet Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
author_sort Aghamohammadi A
collection DOAJ
description Recurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin the frequency of ENT symptoms among the patients with antibody deficiencies, 83 antibody deficient patients were studied from 1980 during a 20-year period, and their ENT symptoms were registered.This historical cohort study comprised of 83 patients including 25 X link agammaglubulinemi, (XLA) 40 common variable immunodeficiency (CVID), 14 IgA deficiency (IgA-D); 50 male, 33 female. The average length of time between onset and diagnosis was 40 months in our patients. Seventy-two of our patients (86.7%), had recurrent ENT symptoms (sinusitis, otitis and/or mastoidits) during the course of their disease. Each XLA patient had experienced 3.6 episodes of otitis per year, but after diagnosis it decreased to 0.7 episode per year. This decrease was about 5.8 folds in CVID (3.8 to 0.65) and 1.4 folds in IgA (2.2 to 1.6) these results show that a significant number of antibody deficient patients can be present with ENT symptoms (48% in this study). Diagnostic dealy was not much different from other reports. Early diagnosisand treatment of immunodeficiencies significantly prevents recurrent infections hence preventing long time complications
first_indexed 2024-12-18T06:58:25Z
format Article
id doaj.art-8618297a1db84f349581f8f451218ed9
institution Directory Open Access Journal
issn 0044-6025
language English
last_indexed 2024-12-18T06:58:25Z
publishDate 2001-07-01
publisher Tehran University of Medical Sciences
record_format Article
series Acta Medica Iranica
spelling doaj.art-8618297a1db84f349581f8f451218ed92022-12-21T21:17:07ZengTehran University of Medical SciencesActa Medica Iranica0044-60252001-07-01393164168Ear, nose and throat manifestations in patients with primary antibody deficienciesAghamohammadi AJalali FFarhoudi APourpak ZRezaei NKhazali SHHosseini Nik HRecurrent ear, nose, and throat (ENT) infections are common presenting symptoms in patients with primary antibody deficiencies , but sometimes they remain undiagnosed for many years and are subjected to different antibiotics because of a lack of experience in immunodeficiencies. In order to determin the frequency of ENT symptoms among the patients with antibody deficiencies, 83 antibody deficient patients were studied from 1980 during a 20-year period, and their ENT symptoms were registered.This historical cohort study comprised of 83 patients including 25 X link agammaglubulinemi, (XLA) 40 common variable immunodeficiency (CVID), 14 IgA deficiency (IgA-D); 50 male, 33 female. The average length of time between onset and diagnosis was 40 months in our patients. Seventy-two of our patients (86.7%), had recurrent ENT symptoms (sinusitis, otitis and/or mastoidits) during the course of their disease. Each XLA patient had experienced 3.6 episodes of otitis per year, but after diagnosis it decreased to 0.7 episode per year. This decrease was about 5.8 folds in CVID (3.8 to 0.65) and 1.4 folds in IgA (2.2 to 1.6) these results show that a significant number of antibody deficient patients can be present with ENT symptoms (48% in this study). Diagnostic dealy was not much different from other reports. Early diagnosisand treatment of immunodeficiencies significantly prevents recurrent infections hence preventing long time complicationshttp://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/1150.pdf&manuscript_id=1150Primary antibody deficienciesSinusitisOtitis media
spellingShingle Aghamohammadi A
Jalali F
Farhoudi A
Pourpak Z
Rezaei N
Khazali SH
Hosseini Nik H
Ear, nose and throat manifestations in patients with primary antibody deficiencies
Acta Medica Iranica
Primary antibody deficiencies
Sinusitis
Otitis media
title Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_full Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_fullStr Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_full_unstemmed Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_short Ear, nose and throat manifestations in patients with primary antibody deficiencies
title_sort ear nose and throat manifestations in patients with primary antibody deficiencies
topic Primary antibody deficiencies
Sinusitis
Otitis media
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/1150.pdf&manuscript_id=1150
work_keys_str_mv AT aghamohammadia earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT jalalif earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT farhoudia earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT pourpakz earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT rezaein earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT khazalish earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies
AT hosseininikh earnoseandthroatmanifestationsinpatientswithprimaryantibodydeficiencies